Twin Lakes Capital Management, LLC Crispr Therapeutics Ag Transaction History
Twin Lakes Capital Management, LLC
- $150 Million
- Q3 2024
A detailed history of Twin Lakes Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 682 shares of CRSP stock, worth $27,696. This represents 0.02% of its overall portfolio holdings.
Number of Shares
682
Previous 682
-0.0%
Holding current value
$27,696
Previous $36,000
11.11%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
59.1MCall Options Held
1.09MPut Options Held
1.9M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$364 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA7.93MShares$322 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$122 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$120 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$113 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.17B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....